|
|
||||||||




*
Department of Microbiology, Dartmouth Medical School, Lebanon, NH 03756;
Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455;
Diabetes Division, University of Massachusetts Medical School, Worcester, MA 01605; and
§
Department of Immunobiology, Yale University, New Haven, CT 06520
Brief treatment with
CD154 Ab has been shown to prevent acute
graft versus host disease (aGvHD). We extend these data to show that in
the absence of CD154 function, donor T cells are unable to expand or
generate high level anti-host CTL activity. Using transgenic (Tg)
alloreactive CD8+ T cells adoptively transferred into
allogeneic recipients, we show that short-term expansion of the
CD8+ Tg T cells occurred in the absence of Th cells, and
this short-term expansion could be facilitated with an agonistic
CD40. While CD40 agonism could enhance short-term expansion,
sustained expansion of CD8+ Tg T cells required bona fide
CD154-expressing CD4+ alloreactive Th cells. While CD154
was necessary for CD8+ Tg T cell sustained expansion, IL-2
was also implicated as essential. These observations suggest
CD154
therapy in GvHD is effective because the treatment causes an abortive
CD8 alloresponse leading to the exhaustion or deletion of alloreactive
CD8+ clones preventing the development of
disease.
This article has been cited by other articles:
![]() |
G. Socie and B. R. Blazar Acute graft-versus-host disease: from the bench to the bedside Blood, November 12, 2009; 114(20): 4327 - 4336. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chakraverty, B. Flutter, F. Fallah-Arani, H.-S. Eom, T. Means, G. Andreola, S. Schwarte, J. Buchli, P. Cotter, G. Zhao, et al. The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells J. Immunol., November 15, 2008; 181(10): 6820 - 6828. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bartholdy, S. O. Kauffmann, J. P. Christensen, and A. R. Thomsen Agonistic Anti-CD40 Antibody Profoundly Suppresses the Immune Response to Infection with Lymphocytic Choriomeningitis Virus J. Immunol., February 1, 2007; 178(3): 1662 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shorts, J. M. Weiss, J.-K. Lee, L. A. Welniak, J. Subleski, T. Back, W. J. Murphy, and R. H. Wiltrout Stimulation through CD40 on Mouse and Human Renal Cell Carcinomas Triggers Cytokine Production, Leukocyte Recruitment, and Antitumor Responses that Can Be Independent of Host CD40 Expression. J. Immunol., June 1, 2006; 176(11): 6543 - 6552. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R Blazar and W. J Murphy Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD) Phil Trans R Soc B, September 29, 2005; 360(1461): 1747 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation J. Immunol., November 15, 2004; 173(10): 5923 - 5928. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Marzo, V. Vezys, K. D. Klonowski, S.-J. Lee, G. Muralimohan, M. Moore, D. F. Tough, and L. Lefrancois Fully Functional Memory CD8 T Cells in the Absence of CD4 T Cells J. Immunol., July 15, 2004; 173(2): 969 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. D'Souza and L. Lefrancois IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion J. Immunol., December 1, 2003; 171(11): 5727 - 5735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, L. Meng, R. W. Busuttil, M. H. Sayegh, and J. W. Kupiec-Weglinski Activation of Alloreactive CD8+ T Cells Operates Via CD4-Dependent and CD4-Independent Mechanisms and Is CD154 Blockade Sensitive J. Immunol., March 15, 2003; 170(6): 3024 - 3028. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Murphy, L. Welniak, T. Back, J. Hixon, J. Subleski, N. Seki, J. M. Wigginton, S. E. Wilson, B. R. Blazar, A. M. Malyguine, et al. Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses J. Immunol., March 1, 2003; 170(5): 2727 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gonzalez, S. A. Quezada, B. R. Blazar, A. Panoskaltsis-Mortari, A. Y. Rudensky, and R. J. Noelle The Balance Between Donor T Cell Anergy and Suppression Versus Lethal Graft-Versus-Host Disease Is Determined by Host Conditioning J. Immunol., November 15, 2002; 169(10): 5581 - 5589. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, L. Meng, F. Gao, R. W. Busuttil, and J. W. Kupiec-Weglinski Allograft Rejection by Primed/Memory CD8+ T Cells Is CD154 Blockade Resistant: Therapeutic Implications for Sensitized Transplant Recipients J. Immunol., October 15, 2002; 169(8): 4667 - 4673. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, X.-D. Shen, F. Gao, A. J. Coito, B. A. Wasowska, A. Salama, I. Schmitt, R. W. Busuttil, M. H. Sayegh, and J. W. Kupiec-Weglinski The CD154-CD40 T Cell Costimulation Pathway Is Required for Host Sensitization of CD8+ T Cells by Skin Grafts Via Direct Antigen Presentation J. Immunol., August 1, 2002; 169(3): 1270 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Roth, J. Schwartzkopff, and H. Pircher CD40 Ligation in the Presence of Self-Reactive CD8 T Cells Leads to Severe Immunopathology J. Immunol., May 15, 2002; 168(10): 5124 - 5129. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Wilcox, A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, et al. Expression of Functional CD137 Receptor by Dendritic Cells J. Immunol., May 1, 2002; 168(9): 4262 - 4267. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response J. Immunol., May 1, 2002; 168(9): 4382 - 4390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhan, J. L. Brady, R. M. Sutherland, and A. M. Lew Without CD4 Help, CD8 Rejection of Pig Xenografts Requires CD28 Costimulation But Not Perforin Killing J. Immunol., December 1, 2001; 167(11): 6279 - 6285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morel, A. Truneh, R. W. Sweet, D. Olive, and R. T. Costello The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity J. Immunol., September 1, 2001; 167(5): 2479 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions Blood, July 15, 2001; 98(2): 467 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Gorbachev, P. S. Heeger, and R. L. Fairchild CD4+ and CD8+ T Cell Priming for Contact Hypersensitivity Occurs Independently of CD40-CD154 Interactions J. Immunol., February 15, 2001; 166(4): 2323 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhan, A. J. Corbett, J. L. Brady, R. M. Sutherland, and A. M. Lew CD4 Help-Independent Induction of Cytotoxic CD8 Cells to Allogeneic P815 Tumor Cells Is Absolutely Dependent on Costimulation J. Immunol., October 1, 2000; 165(7): 3612 - 3619. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Jones, A. Van Maurik, M. Hara, B. M. Spriewald, O. Witzke, P. J. Morris, and K. J. Wood CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection J. Immunol., July 15, 2000; 165(2): 1111 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Wagar, M. A. Cromwell, L. D. Shultz, B. A. Woda, J. L. Sullivan, R. M. Hesselton, and D. L. Greiner Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice J. Immunol., July 1, 2000; 165(1): 518 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Matthews, M. Wadhwa, C. Bird, F. E. Borras, and C. V. Navarrete Sustained Expression of CD154 (CD40L) and Proinflammatory Cytokine Production by Alloantigen-Stimulated Umbilical Cord Blood T Cells J. Immunol., June 15, 2000; 164(12): 6206 - 6212. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice J. Immunol., June 1, 2000; 164(11): 6067 - 6074. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Z. Yu, S. J. Bidwell, P. J. Martin, and C. Anasetti CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice J. Immunol., May 1, 2000; 164(9): 4564 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Andreasen, J. E. Christensen, O. Marker, and A. R. Thomsen Role of CD40 Ligand and CD28 in Induction and Maintenance of Antiviral CD8+ Effector T Cell Responses J. Immunol., April 1, 2000; 164(7): 3689 - 3697. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Seung, N. Iwakoshi, B. A. Woda, T. G. Markees, J. P. Mordes, A. A. Rossini, and D. L. Greiner Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice Blood, March 15, 2000; 95(6): 2175 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Garceau, Y. Kosaka, S. Masters, J. Hambor, R. Shinkura, T. Honjo, and R. J. Noelle Lineage-Restricted Function of Nuclear Factor {kappa}B-Inducing Kinase (Nik) in Transducing Signals via Cd40 J. Exp. Med., January 17, 2000; 191(2): 381 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lefrancois, J. D. Altman, K. Williams, and S. Olson Soluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells J. Immunol., January 15, 2000; 164(2): 725 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lefrancois, S. Olson, and D. Masopust A Critical Role for Cd40-Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response J. Exp. Med., November 1, 1999; 190(9): 1275 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shepherd and N. I. Kerkvliet Disruption of CD154:CD40 Blocks Generation of Allograft Immunity Without Affecting APC Activation J. Immunol., September 1, 1999; 163(5): 2470 - 2477. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |